Registered Trials

• NCT05374954

  Phase 3

  China

  Total Enrollment: 4,200

  Official Trial Registration:

  • NCT05374954(Opens in new tab/window)

• NCT05323461

  Phase 3

  Total Enrollment: 1,800

  Official Trial Registration:

  • NCT05323461(Opens in new tab/window)

• NCT05204589

  Phase 3

  China

  Total Enrollment: 10,420

  Official Trial Registration:

  • NCT05204589(Opens in new tab/window)

• IRCT20210206050259N3

  Phase 3

  Iran (Islamic Republic of)

  Total Enrollment: 41,128

  Official Trial Registration:

  • IRCT20210206050259N3(Opens in new tab/window)

• IRCT20201214049709N3

  Phase 3

  Iran (Islamic Republic of)

  Total Enrollment: 41,128

  Official Trial Registration:

  • IRCT20201214049709N3(Opens in new tab/window)

• NCT05293665

  Phase 3

  United States of America

  Total Enrollment: 1,010

  Official Trial Registration:

  • NCT05293665(Opens in new tab/window)

• NCT05249816

  Phase 3

  United Arab Emirates

  Total Enrollment: 1,000

  Official Trial Registration:

  • NCT05249816(Opens in new tab/window)

• ChiCTR2000034780

  Phase 3

  United Arab Emirates

  Total Enrollment: 45,000

  Official Trial Registration:

  • ChiCTR2000034780(Opens in new tab/window)

• NCT04510207

  Phase 3

  Bahrain, Egypt, Jordan, United Arab Emirates

  Total Enrollment: 45,000

  Official Trial Registration:

  • NCT04510207(Opens in new tab/window)

• NCT04612972

  Phase 3

  Peru

  Total Enrollment: 6,000

  Official Trial Registration:

  • NCT04612972(Opens in new tab/window)

• NCT05163652

  Phase 3

  China

  Total Enrollment: 432

  Official Trial Registration:

  • NCT05163652(Opens in new tab/window)

• NCT04560881, BIBP2020003AR

  Phase 3

  Argentina

  Total Enrollment: 3,000

  Official Trial Registration:

  • NCT04560881(Opens in new tab/window)
  • BIBP2020003AR(Opens in new tab/window)

• NCT04917523

  Phase 3

  United Arab Emirates

  Total Enrollment: 1,800

  Official Trial Registration:

  • NCT04917523(Opens in new tab/window)

• NCT04984408

  Phase 3

  Mozambique

  Total Enrollment: 8,825

  Official Trial Registration:

  • NCT04984408(Opens in new tab/window)

• NCT05323435

  Phase 2/3

  Total Enrollment: 1,950

  Official Trial Registration:

  • NCT05323435(Opens in new tab/window)

• NCT05308602

  Phase 2

  Total Enrollment: 480

  Official Trial Registration:

  • NCT05308602(Opens in new tab/window)

• NCT04988048

  Phase 2

  Argentina

  Total Enrollment: 1,760

  Official Trial Registration:

  • NCT04988048(Opens in new tab/window)

• NCT04962906

  Phase 2

  Argentina

  Total Enrollment: 150

  Official Trial Registration:

  • NCT04962906(Opens in new tab/window)

• NCT04983537

  Phase 2

  Argentina

  Total Enrollment: 120

  Official Trial Registration:

  • NCT04983537(Opens in new tab/window)

• NCT05409300

  Phase 2

  Guinea

  Total Enrollment: 400

  Official Trial Registration:

  • NCT05409300(Opens in new tab/window)

• NCT05162482

  Phase 2

  Pakistan

  Total Enrollment: 1,680

  Official Trial Registration:

  • NCT05162482(Opens in new tab/window)

• NCT04998240

  Phase 2

  Mozambique

  Total Enrollment: 360

  Official Trial Registration:

  • NCT04998240(Opens in new tab/window)

• TCTR20210920005

  Phase 2

  Thailand

  Total Enrollment: 500

  Official Trial Registration:

  • TCTR20210920005(Opens in new tab/window)

• NCT05172193

  Phase 2

  Total Enrollment: 800

  Official Trial Registration:

  • NCT05172193(Opens in new tab/window)

• IRCT20171122037571N3

  Phase 1/2

  Iran (Islamic Republic of)

  Total Enrollment: 500

  Official Trial Registration:

  • IRCT20171122037571N3(Opens in new tab/window)

• NCT05109559

  Phase 1/2

  Thailand

  Total Enrollment: 690

  Official Trial Registration:

  • NCT05109559(Opens in new tab/window)

• ChiCTR2000032459

  Phase 1/2

  China

  Total Enrollment: 640

  Official Trial Registration:

  • ChiCTR2000032459(Opens in new tab/window)